JP2015535290A5 - - Google Patents

Download PDF

Info

Publication number
JP2015535290A5
JP2015535290A5 JP2015540801A JP2015540801A JP2015535290A5 JP 2015535290 A5 JP2015535290 A5 JP 2015535290A5 JP 2015540801 A JP2015540801 A JP 2015540801A JP 2015540801 A JP2015540801 A JP 2015540801A JP 2015535290 A5 JP2015535290 A5 JP 2015535290A5
Authority
JP
Japan
Prior art keywords
amino
alkyl
carbocyclyl
carbamoyl
formyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540801A
Other languages
English (en)
Japanese (ja)
Other versions
JP6479670B2 (ja
JP2015535290A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067972 external-priority patent/WO2014071134A1/en
Publication of JP2015535290A publication Critical patent/JP2015535290A/ja
Publication of JP2015535290A5 publication Critical patent/JP2015535290A5/ja
Application granted granted Critical
Publication of JP6479670B2 publication Critical patent/JP6479670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540801A 2012-11-05 2013-11-01 7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法 Active JP6479670B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261722339P 2012-11-05 2012-11-05
US61/722,339 2012-11-05
US201361845399P 2013-07-12 2013-07-12
US61/845,399 2013-07-12
PCT/US2013/067972 WO2014071134A1 (en) 2012-11-05 2013-11-01 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019020153A Division JP2019089817A (ja) 2012-11-05 2019-02-06 7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法

Publications (3)

Publication Number Publication Date
JP2015535290A JP2015535290A (ja) 2015-12-10
JP2015535290A5 true JP2015535290A5 (enExample) 2016-12-08
JP6479670B2 JP6479670B2 (ja) 2019-03-06

Family

ID=50628080

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015540801A Active JP6479670B2 (ja) 2012-11-05 2013-11-01 7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法
JP2019020153A Pending JP2019089817A (ja) 2012-11-05 2019-02-06 7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法
JP2020206038A Pending JP2021050230A (ja) 2012-11-05 2020-12-11 7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019020153A Pending JP2019089817A (ja) 2012-11-05 2019-02-06 7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法
JP2020206038A Pending JP2021050230A (ja) 2012-11-05 2020-12-11 7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法

Country Status (8)

Country Link
US (3) US9682948B2 (enExample)
EP (2) EP3369730B1 (enExample)
JP (3) JP6479670B2 (enExample)
CN (2) CN104812744B (enExample)
AU (3) AU2013337742B2 (enExample)
CA (1) CA2890075C (enExample)
ES (1) ES2823237T3 (enExample)
WO (1) WO2014071134A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
EP2877461B1 (en) 2012-07-27 2018-05-09 Emory University Heterocyclic flavone derivatives, compositions, and methods related thereto
WO2014071134A1 (en) * 2012-11-05 2014-05-08 Emory University 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
JP2021505629A (ja) * 2017-12-11 2021-02-18 トニックス ファーマ ホールディングス リミテッド 認知症および神経変性状態における興奮、精神病および認知機能低下のためのシクロベンザプリン処置
CN108299367B (zh) * 2018-01-26 2022-04-12 南阳师范学院 一种芹菜苷元氨基甲酸酯类化合物、其制备方法及应用
EP3787617A4 (en) * 2018-05-03 2021-09-08 Georgia State University Research Foundation Inc. RESPIRATORY SYNCYTIAL VIRUS (RSV) REPLICATION INHIBITORS AND THEIR USES
CN110577532B (zh) * 2018-06-08 2022-06-03 江苏威凯尔医药科技有限公司 原肌球蛋白受体激酶抑制剂及其制备方法和应用
EP3831821A4 (en) * 2018-08-01 2022-05-11 Shaanxi Micot Technology Limited Company Compound for treating nervous system diseases and use thereof
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
AU2019384963B2 (en) 2018-11-19 2022-05-26 Zogenix International Limited Methods of treating Rett syndrome using fenfluramine
CN109574975B (zh) * 2019-01-14 2023-07-14 上海博芮健制药有限公司 7,8-二羟基黄酮衍生物的晶型及其制备方法和应用
WO2020154434A1 (en) * 2019-01-24 2020-07-30 Pharmatrophix, Inc. Compositions and methods for treating and preventing cognitive dysfunction
CN111825649A (zh) * 2019-04-15 2020-10-27 上海博芮健制药有限公司 7,8-二羟基黄酮衍生物的纯化方法
CN114075162A (zh) * 2020-08-20 2022-02-22 上海博芮健制药有限公司 7,8-二羟基黄酮衍生物的晶型b及其制备方法、应用
CN112168976B (zh) * 2020-10-15 2022-11-04 天津科技大学 一种黄酮衍生物前药及合成和作为抗肿瘤药物的应用
CN118369095A (zh) * 2021-07-15 2024-07-19 爱默蕾大学 用取代的黄酮治疗骨病的方法
CN118251415A (zh) * 2021-10-29 2024-06-25 清华大学 用于治疗或诊断精神分裂症的方法和产品
CA3237199A1 (en) 2021-11-02 2023-05-11 Flare Therapeutics Inc. Pparg inverse agonists and uses thereof
TWI887826B (zh) * 2022-11-02 2025-06-21 美商佩特拉製藥公司 用於治療疾病之磷酸肌醇3-激酶(pi3k)異位色烯酮抑制劑

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
WO2002024676A1 (en) * 2000-09-21 2002-03-28 Teva Pharmaceuticals Industries, Ltd. N-disubstituted carbamoyloxy flavones
US20020160983A1 (en) * 2001-03-16 2002-10-31 Alberto Bargiotti Substituted benzopyranones as telomerase inhibitors
EP1383465B1 (en) 2001-03-29 2011-08-10 Michael Davis Acute pharmacologic augmentation of psychotherapy with d-cycloserine
US20030125264A1 (en) * 2001-12-29 2003-07-03 Kimberly-Clark Worldwide, Inc. Methods For Treating Wounds
PT1846394E (pt) * 2005-02-04 2012-01-05 Astrazeneca Ab Derivados de pirazolilaminopiridina úteis como inibidores da quinase
WO2007148158A1 (en) 2006-06-21 2007-12-27 Piramal Life Sciences Limited Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation
CZ300589B6 (cs) 2006-09-04 2009-06-24 Univerzita Palackého Deriváty 2-fenyl-3-hydroxychinolin-4(1H)-onu a zpusob jejich prípravy a použití
CN102143744B (zh) * 2008-07-25 2016-08-31 爱默蕾大学 7,8-二羟基黄酮及其衍生物在制备治疗抑郁的药物中的用途
WO2010107866A2 (en) 2009-03-20 2010-09-23 Emory University Catecholamine derivatives for obesity and neurological disorders
CN101591319B (zh) * 2009-06-22 2011-12-21 复旦大学 黄酮类衍生物及其在制备药物组合物中的用途
EP2473495A1 (en) * 2009-09-18 2012-07-11 Almac Discovery Limited Pharmaceutical compounds
CN105566272A (zh) * 2010-06-09 2016-05-11 爱默蕾大学 TrkB激动剂及其用途
WO2014071134A1 (en) * 2012-11-05 2014-05-08 Emory University 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

Similar Documents

Publication Publication Date Title
JP2015535290A5 (enExample)
EP4570250A3 (en) Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
JP2011529054A5 (enExample)
JP2011524850A5 (enExample)
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
JP2015516395A5 (enExample)
EA201170198A1 (ru) Фармацевтические композиции, содержащие лиганды рецептора дофамина
JP2013032389A5 (enExample)
JP2011037901A5 (enExample)
JP2014198723A5 (enExample)
JP2015501783A5 (enExample)
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
WO2009013212A3 (en) Dual modulators of 5-ht2a and d3 receptors
EA201000280A1 (ru) Фармацевтические композиции, содержащие лиганды дофаминовых рецепторов, и способы лечения с помощью лигандов дофаминовых рецепторов
JP2009537554A5 (enExample)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
RU2020125170A (ru) Композиции и способы улучшения биодоступности 5-гидрокситриптофана
ATE507214T1 (de) Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität
JP2002525280A5 (enExample)
JP2012036212A5 (enExample)
EA201100287A1 (ru) Композиция ропинирола
EA200970849A1 (ru) Трициклические производные изохинолина для лечения ожирения
EA201000926A1 (ru) Пиперазины в качестве агентов против ожирения
MX2012000685A (es) Compuesto de 3-fenoximetilpirrolidina.
JP2013032308A5 (enExample)